feed,title,long_url,short_url
Benzinga,Blueprint Medicines Stock Gets Price Target Cut Amid Lower Than Expected Ayvakit Uptake,https://benzinga.com/general/biotech/22/11/29529197/blueprint-medicines-stock-gets-price-target-cut-amid-lower-than-expected-ayvakit-uptake,https://bit.ly/3NrScVb
